paul barr, md: use of bruton's tyrosine kinase inhibitor
Published 8 years ago • 238 plays • Length 2:55Download video MP4
Download video MP3
Similar videos
-
1:11
paul barr, md: phase iii data to support usage of bruton's tkis
-
4:23
an overview of bruton tyrosine kinase inhibition
-
1:30
paul barr, md: dose intensity
-
8:41
use of vegf-targeted tyrosine kinase inhibitors
-
13:55
debate: optimal approach for the management of cll patients with del(17p) - novel agents
-
15:57
part 2 investigator insights: emerging multikinase inhibitors in the treatment of thyroid cancers
-
1:42
dr. barzi on surgical advances in pancreatic cancer
-
21:19
cll: sequencing monotherapy vs. combination therapy
-
1:12
tanios bekaii-saab, md: mechanisms of action in regorafenib
-
1:18
barolat neuroscience - minimally invasive surgery
-
0:38
barolat neuroscience - neurosurgeon
-
20:23
cll: update on approved tkis and their use in clinical practice
-
11:23
debate: best approach for multiple relapsed cll after chemoimmunotherapy - kinase inhibitor
-
1:11
barolat neuroscience - chronic back pain management
-
1:58
julius chapiro m.d., yale radiology and biomedical imaging @ rsna 2018
-
3:24
medical profiling, by prof. elaine holmes & manfred spraul (for research use only)
-
6:14
liberum bio - desktop protein manufacturing with the push of a button | indiebio | sosv
-
2:22
barolat neuromodulation for chronic pain
-
18:20
functional hyperaemia simulation to determine neuronal specificity of bold fmri along cortical depth